Author(s):
Shrikant Dod, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti
Email(s):
shrikantdod2000@gmail.com
DOI:
10.52711/0974-360X.2026.00173 
Address:
Shrikant Dod*, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti
Department of Pharmaceutics, Kamla Nehru College of Pharmacy, Butibori, Nagpur, Maharashtra, India - 441108.
*Corresponding Author
Published In:
Volume - 19,
Issue - 3,
Year - 2026
ABSTRACT:
The purpose of this study was to use a polymeric nanoparticulate drug delivery technology to increase the therapeutic effectiveness of triamcinolone acetonide (TA) for the treatment of uveitis. A modified emulsification/solvent diffusion approach was used to manufacture polyethylene glycol 4000(PEG 4000) nanosuspensions while optimizing processing variables influencing drug loading and particle size. In vitro release studies, X-ray powder diffraction, differential scanning calorimetry, and scanning electron microscopy are examples of physicochemical characterisation. Confirmed the formulation's properties. In vitro studies using a 195nm nanosuspension demonstrated significant improvements in TA release compared to conventional formulations. Therapeutic efficacy evaluations in various groups further underscored the nanosuspensions superior effectiveness in treating uveitis. This approach highlights the potential of sustained-release TA nanosuspensions as promising topical treatments, potentially enhancing patient compliance. Additionally, the review discusses incorporating immunosuppressant into ophthalmic nanodrug delivery systems, emphasizing their benefits in improving drug solubility, bioavailability, eye-targeted specificity, and minimizing systemic side effects, thereby advancing ophthalmic therapeutics.
Cite this article:
Shrikant Dod, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti. Innovative Nanosuspension Formulation for Targeted Uveitis Therapy. Research Journal Pharmacy and Technology. 2026;19(3):1211-0. doi: 10.52711/0974-360X.2026.00173
Cite(Electronic):
Shrikant Dod, Nitin Padole, Pankaj Dhapke, Nilakshi Dhoble, Jagdish Baheti. Innovative Nanosuspension Formulation for Targeted Uveitis Therapy. Research Journal Pharmacy and Technology. 2026;19(3):1211-0. doi: 10.52711/0974-360X.2026.00173 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-3-34
REFERENCES:
1. Tsirouki, T.; Dastiridou, A.; Symeonidis, C.; Tounakaki, O.; Brazitikou, I.; Kalogeropoulos, C.; Androudi, S. A Focus on the Epidemiology of Uveitis. Ocul. Immunol. Inflamm. 2018; 26(1): 2–16. https://doi.org/10.1080/09273948.2017.1279330
2. Dunn, J. P. Uveitis. Prim. Care Clin. Off. Pract. 2015; 42(3): 305–323. https://doi.org/10.1016/j.pop.2015.05.002
3. Lin, P.; Suhler, E. B.; Rosenbaum, J. T. The Future of Uveitis Treatment. Ophthalmology. 2014; 121(1): 365–376. https://doi.org/10.1016/j.ophtha.2013.07.017.
4. Prete, M.; Dammacco, R.; Fatone, M. C.; Racanelli, V. Autoimmune Uveitis: Clinical, Pathogenetic, and Therapeutic Features. Clin. Exp. Med. 2016; 16(2): 125–136. https://doi.org/10.1007/s10238-015-0345-6
5. Lee, R. W.; Nicholson, L. B.; Sen, H. N.; Chan, C. C.; Wei, L.; Nussenblatt, R. B.; Dick, A. D. Autoimmune and Autoinflammatory Mechanisms in Uveitis. Semin. Immunopathol. 2014; 36(5): 581–594. https://doi.org/10.1007/s00281-014-0433-9
6. Forrester, J. V.; Kuffova, L.; Dick, A. D. Autoimmunity, Autoinflammation, and Infection in Uveitis. Am. J. Ophthalmol. 2018; 189: 77–85. https://doi.org/10.1016/j.ajo.2018.02.019
7. Lee, R. W.; Schewitz, L. P.; Raveney, B. J. E.; Dick, A. D. Steroid Sensitivity in Uveitis. In Essentials in Ophthalmology: Uveitis and Immunological Disorders; Pleyer, U., Forrester, J. V., Eds.; Springer Berlin Heidelberg: Berlin, Heidelberg, 2009; 45–54. https://doi.org/10.1007/978-3-540-69459-5
8. Sulaiman, R. S.; Kadmiel, M.; Cidlowski, J. A. Glucocorticoid Receptor Signaling in the Eye. Steroids 2018; 133: 60–66. https://doi.org/10.1016/j.steroids.2017.11.002
9. Foster, C. S.; Vitale, A. T. Diagnosis & Treatment of Uveitis, 2nd ed.; JP Medical Ltd: New Delhi, 2013.
10. Lajavardi, L.; Camelo, S.; Agnely, F.; Luo, W.; Goldenberg, B.; Naud, M.-C.; Behar-Cohen, F.; de Kozak, Y.; Bochot, A. New Formulation of Vasoactive Intestinal Peptide Using Liposomes in Hyaluronic Acid Gel for Uveitis. J. Control. Release. 2009; 139(1): 22–30. https://doi.org/10.1016/j.jconrel.2009.05.033
11. Leone, F.; Cavalli, R. Drug Nanosuspensions: A ZIP Tool Between Traditional and Innovative Pharmaceutical Formulations. Expert Opin. Drug Deliv. 2015; 12(10): 1607–1625. https://doi.org/10.1517/17425247.2015.1043886
12. Stoccoro, A.; Karlsson, H. L.; Coppedè, F.; Migliore, L. Epigenetic Effects of Nano-Sized Materials. Toxicology. 2013; 313(1): 3–14. https://doi.org/10.1016/j.tox.2012.12.002
13. Lin, Z.; Hong, M. Femtosecond Laser Precision Engineering: From Micron, Submicron, to Nanoscale. Ultrafast Sci. 2021; 2021, Article 9783514. https://doi.org/10.34133/2021/9783514
14. Yadav, K. S.; Soni, G.; Choudhary, D.; Khanduri, A.; Bhandari, A.; Joshi, G. Microemulsions for Enhancing Drug Delivery of Hydrophilic Drugs: Exploring Various Routes of Administration. Med. Drug Discov. 2023; 20: 100162. https://doi.org/10.1016/j.medidd.2023.100162
15. Kumari, B. Ocular Drug Delivery System: Approaches to Improve Ocular Bioavailability. GSC Biol. Pharm. Sci. 2019; 6 (3): 1–10. https://doi.org/10.30574/gscbps.2019.6.3.0030
16. Almeida, H.; Amaral, M. H.; Lobão, P.; Lobo, J. M. In Situ Gelling Systems: A Strategy to Improve the Bioavailability of Ophthalmic Pharmaceutical Formulations. Drug Discov. Today. 2014; 19(4): 400–412. https://doi.org/10.1016/j.drudis.2013.10.001
17. Ali, H. S. M.; York, P.; Blagden, N. Preparation of Hydrocortisone Nanosuspension through a Bottom-Up Nanoprecipitation Technique Using Microfluidic Reactors. Int. J. Pharm. 2009; 375(1–2): 107–113. https://doi.org/10.1016/j.ijpharm.2009.03.029
18. Ali, H. S. M.; York, P.; Ali, A. M.; Blagden, N. Hydrocortisone Nanosuspensions for Ophthalmic Delivery: A Comparative Study between Microfluidic Nanoprecipitation and Wet Milling. J. Control. Release. 2011; 149(2): 175–181. https://doi.org/10.1016/j.jconrel.2010.10.007
19. Wyatt, N. B.; Gunther, C. M.; Liberatore, M. W. Increasing Viscosity in Entangled Polyelectrolyte Solutions by the Addition of Salt. Polymer. 2011; 52(11): 2437–2444. https://doi.org/10.1016/j.polymer.2011.03.053
20. Sutradhar, K. B.; Khatun, S.; Luna, I. P. Increasing Possibilities of Nanosuspension. J. Nanotechnol. 2013; 2013: 346581. https://doi.org/10.1155/2013/346581
21. Kulkarni, R. R.; Phadtare, D. G.; Saudagar, R. B. A Novel Approach towards Nanosuspension. Asian J. Pharm. Res. 2015; 5(4): 186–194. https://doi.org/10.5958/2231-5691.2015.00029.5
22. Patel, H. M.; Patel, B. B.; Shah, C. N.; Shah, D. P. Nanosuspension Technologies for Delivery of Poorly Soluble Drugs: A Review. Res. J. Pharm. Tech. 2016; 9(5): 625–632. https://doi.org/10.5958/0974-360X.2016.00120.7
23. Sabzevari, A.; Adibkia, K.; Hashemi, H.; Hedayatfar, A.; Mohsenzadeh, N.; Atyabi, F.; Ghahremani, M. H.; Dinarvand, R. Polymeric Triamcinolone Acetonide Nanoparticles as a New Alternative in the Treatment of Uveitis: In Vitro and In Vivo Studies. Eur. J. Pharm. Biopharm. 2013; 84(1): 63–71. https://doi.org/10.1016/j.ejpb.2012.12.010
24. Chaudhary, S. A.; Patel, D. M.; Patel, J. K.; Patel, D. H. Solvent Emulsification Evaporation and Solvent Emulsification Diffusion Techniques for Nanoparticles. In Emerging Technologies for Nanoparticle Manufacturing; Patel, J. K., Pathak, Y. V., Eds.; Springer International Publishing: Cham, Switzerland, 2021; pp 287–300. https://doi.org/10.1007/978-3-030-50703-9_12
25. Mendoza-Muñoz, N.; Alcalá-Alcalá, S.; Quintanar-Guerrero, D. Preparation of Polymer Nanoparticles by the Emulsification-Solvent Evaporation Method: From Vanderhoff’s Pioneer Approach to Recent Adaptations. In Polymer Nanoparticles for Nanomedicines: A Guide for Their Design, Preparation and Development; Springer: Cham, Switzerland, 2016; pp 87–121. DOI: 10.1016/S0168-3659(02)00320-6
26. Padole, N. N.; Majgavali, N. V.; Meshram, M. A.; Padole, N. N. Synthesis and Characterization of Silver Nanoparticles by Chemical Route for Potential Applications: A Review. Purakala. 2022; 31(2). https://doi.org/10.1080/21691401.2018.1489262
27. Prabhakar, C.; Krishna, K. B. A Review on Polymeric Nanoparticles. Res. J. Pharm. Tech. 2011; 4(4), 496–498.
28. Borra, S. P.; Eswaraiah, M. C.; Reddy, G. K. Effect of Polysorbate 80 and Particle Size of Budesonide API on In-Vitro Dissolution Profiles of Budesonide MUPS Tablets 9 mg. Res. J. Pharm. Tech. 2018; 11(10): 4285–4295. https://doi.org/10.5958/0974-360X.2018.00785.0
29. Mohite, S. A.; Padole, N. N.; Avari, J. G. Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry. 2020; 8(3), 111–118. https://doi.org/10.36673/AJPAMC.2020.v08.i03.A14
30. Priyanka, M.; Nilakshi, D.; Nitin, P.; Pankaj, D.; Jagdish, B. Brucine-Loaded Nanoparticles: Advancements in Targeted Drug Delivery Systems. Asian J. Pharm. Res. Dev. 2024; 12(3): 214–221. https://doi.org/10.22270/ajprd.v11i3.1424
31. Merugu, M.; Aanandhi, V. M. Stability Indicating Method Development and Validation of Semaglutide by RP-HPLC in Pharmaceutical Substance and Pharmaceutical Product. Res. J. Pharm. Technol. 2021; 14(3): 1385–1389. https://doi.org/10.5958/0974-360X.2021.00247.X
32. Alumeri, J. K.; Al-Naely, A. J. Effect of Grape Seed Extract in Blood Parameters Associated with Experimental Thyroid Disorders in White Male Rats. Res. J. Pharm. Technol. 2019; 12(12): 5711–5715. https://doi.org/10.5958/0974-360X.2019.00988.0
33. Maharini, I.; Martien, R.; Nugroho, A. K.; Supanji; Adhyatmika. Validation UV Spectrophotometric Method to Determine Entrapment Efficiency of Ocular Polymeric Nanoparticle Levofloxacin Hemihydrate. Res. J. Pharm. Technol. 2021; 14(10): 5479–5482. https://doi.org/10.52711/0974-360X.2021.00956
34. Krishna, S. R.; Ramu, A.; Vidyadhara, S. Study of Influence of Formulation and Process Variables on Entrapment Efficiency and Particle Size of Floating Micro Balloons of Dipyridamole by DoE. Int. J. Pharm. Pharm. Sci. 2020; 12(10): 85–91. https://doi.org/10.22159/ijpps.2020v12i10.35995
35. Dhoble, N.; Padole, N.; Dhapke, P.; Ghatole, S.; Shahu, A.; Avari, J.; Baheti, J. Enhancement of Antibacterial Activity of Clarithromycin Using Piperine and Its Formulation Development. J. Coastal Life Med. 2023; 11: 1652–1675.
36. Firdous, Z.; Dhapake, P.; Padole, N.; Dhoble, N.; Baheti, J. Different Approaches for Transdermal Nano-Carrier Delivery System. Res. J. Top. Cosmet. Sci. 2023; 14(2): 94–104. https://doi.org/10.52711/2321-5844.2023.00015
37. Walters, K. A.; Brain, K. R. Topical and Transdermal Delivery. In Pharmaceutical Preformulation and Formulation; Gibson, M., Ed.; CRC Press: Boca Raton, FL, 2009; pp 475–538. https://doi.org/10.1201/b14413-20
38. Juretić, M. Biopharmaceutical Evaluation of Ophthalmic Excipients Using In Vitro and Ex Vivo Corneal Models [Doctoral Thesis]; University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology: Zagreb, Croatia, 2019. Available at: https://urn.nsk.hr/urn:nbn:hr:163:952606
39. Khushboo, M.; Naik, K.; Menezes, A.; Naha, A.; Koteshwara, K. B.; Pai, K. G. Formulation and Evaluation of Irbesartan Nanosuspension for Dissolution Enhancement. Res. J. Pharm. Technol. 2017; 10 (9): 3043–3048. https://doi.org/10.5958/0974-360X.2017.00540.6
40. Patel; S.; Patel; A. P. Formulation and Evaluation of Benidipine Nanosuspension. Res. J. Pharm. Technol. 2021; 14(8): 4111–4116. https://doi.org/10.52711/0974-360X.2021.00713
41. Sahu; B. P.; Das; M. K. Nanosuspension for Enhancement of Oral Bioavailability of Felodipine. Appl. Nanosci. 2014; 4(2): 189–197. https://doi.org/10.1007/s13204-012-0189-8
42. Kalvakuntla, S.; Deshpande, M.; Attari, Z.; Kunnatur, K. Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process. Adv. Pharm. Bull. 2016; 6(1): 83–90. https://doi.org/10.15171/apb.2016.013
43. Bhattacharjee, S. DLS and Zeta Potential—What They Are and What They Are Not? J. Control. Release. 2016; 235: 337–351. https://doi.org/10.1016/j.jconrel.2016.07.012
44. Prakash, S.; Mishra, R.; Malviya, R.; Sharma, P. K. Measurement Techniques and Pharmaceutical Applications of Zeta Potential: A Review. J. Chronother. Drug Deliv. 2014; 5(2): 33–40. https://doi.org/10.5330/jcdd.2014.5.2.33
45. Kulkarni, R. R.; Phadtare, D. G.; Saudagar, R. B. A Novel Approach Towards Nanosuspension. Asian J. Pharm. Res. 2015; 5(4): 186–194. https://doi.org/10.5958/2231-5691.2015.00029.5
46. Parekh, K. K.; Paun, J. S.; Soniwala, M. M. Formulation and Evaluation of Nanosuspension to Improve Solubility and Dissolution of Diacerein. Int. J. Pharm. Sci. Res. 2017; 8(4): 1643–1653. https://doi.org/10.13040/IJPSR.0975-8232.8(4).1643-53
47. Mohammed, A.; Abdullah, A. Scanning Electron Microscopy (SEM): A Review. Proceedings of the 2018 International Conference on Hydraulics and Pneumatics—HERVEX, Băile Govora, Romania, November 7–9, 2018; pp 7–9. https://doi.org/10.1109/HERVEX.2018.8615689
48. Mallick, S.; Mahapatra, A. K.; Murthy, P. N.; Patra, R. K. In Vivo Evaluation of Solid Dispersion of Glipizide with Low Viscosity Grade Hydroxypropyl Methylcellulose. Res. J. Pharm. Technol. 2023; 16(2): 555–560. https://doi.org/10.52711/0974-360X.2023.00095
49. Rudyak, V. Y.; Belkin, A. A.; Egorov, V. V. On the Effective Viscosity of Nanosuspensions. Tech. Phys. 2009; 54(8): 1102–1109. https://doi.org/10.1134/S1063784209080039
50. Nayak, S. N.; Bharani, S. S.; Thakur, R. S. Formulation and Evaluation of pH Triggered In Situ Ophthalmic Gel of Moxifloxacin Hydrochloride. Int. J. Pharm. Pharm. Sci. 2012; 4(2): 452–459. https://doi.org/10.13040/IJPSR.0975-8232.4(2).452-459
51. Kaur, I. P.; Kanwar, M. Ocular Preparations: The Formulation Approach. Drug Dev. Ind. Pharm. 2002; 28(5): 473–493. https://doi.org/10.1081/ddc-120003445
52. Nandwani, Y.; Kaur, A.; Bansal, A. K. Generation of Ophthalmic Nanosuspension of Prednisolone Acetate Using a Novel Technology. Pharm. Res. 2021; 38(2): 319–333. https://doi.org/10.1007/s11095-021-02985-2
53. Mudgil, M.; Pawar, P. K. Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application. Sci. Pharm. 2013; 81(2): 591–606. https://doi.org/10.3797/scipharm.1204-16
54. Dandagi, P.; Kerur, S.; Mastiholimath, V.; Gadad, A.; Kulkarni, A. Polymeric Ocular Nanosuspension for Controlled Release of Acyclovir: In Vitro Release and Ocular Distribution. Iran. J. Pharm. Res. 2009; 8(2): 79–86. https://doi.org/10.22037/ijpr.2010.793
55. Mukherjee, S.; Maity, S.; Ghosh, B.; Mondal, A. Accelerated Stability Study of Preformulated Glyburide-Loaded Lyophilized Lipid Nanoparticles. Res. J. Pharm. Technol. 2020; 13(7): 3323–3325. https://doi.org/10.5958/0974-360X.2020.00589.2
56. Padmasree, M.; Vishwanath, B. A.; Patil, S.; Mythili, S.; Kirupakar, B. R. Formulation, Characterization, and Stability Study of Encapsulated Anticancer Drug in Multilayered PEGylated Tumor Targeting Stealth Liposomes. Res. J. Pharm. Technol. 2019; 12(10): 4689–4695. https://doi.org/10.5958/0974-360X.2019.00807.2
57. Alam, M. S.; Sharma, P. Stability Study of Clobetasol Propionate Loaded Tea Tree Oil Nanoemulsion as Per ICH Guidelines. Res. J. Pharm. Technol. 2016; 9(11): 1999–2004. https://doi.org/10.5958/0974-360X.2016.00408.X.